Details

Autor(en) / Beteiligte

• Duran-Struuck, Raimon
• Sondermeijer, Hugo P
• Bühler, Leo
• Alonso-Guallart, Paula
• Zitsman, Jonah
• Kato, Yojiro
• Wu, Anette
• McMurchy, Alicia N
• Woodland, David
• Griesemer, Adam
• Martinez, Mercedes
• Boskovic, Svetlan
• Kawai, Tatsuo
• Cosimi, A Benedict
• Yang, Yong-Guang
• Hu, Zheng
• Wuu, Cheng-Shie
• Slate, Andrea
• Mapara, Markus
• Baker, Sam
• Tokarz, Rafal
• D'Agati, Vivette
• Hammer, Scott
• Pereira, Marcus
• Lipkin, W Ian
• Wekerle, Thomas
• Levings, Megan
• Sykes, Megan

Titel

Effect of Ex Vivo-Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques

Ist Teil von

• Transplantation, 2017-02, Vol.101 (2), p.274

Ort / Verlag

United States

Erscheinungsjahr

2017

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Infusion of recipient regulatory T (Treg) cells promotes durable mixed hematopoietic chimerism and allograft tolerance in mice receiving allogeneic bone marrow transplant (BMT) with minimal conditioning. We applied this strategy in a Cynomolgus macaque model. CD4 CD25 Treg cells that were polyclonally expanded in culture were highly suppressive in vitro and maintained high expression of FoxP3. Eight monkeys underwent nonmyeloablative conditioning and major histocompatibility complex mismatched BMT with or without Treg cell infusion. Renal transplantation (from the same BMT donor) was performed 4 months post-BMT without immunosuppression to assess for robust donor-specific tolerance. Transient mixed chimerism, without significant T cell chimerism, was achieved in the animals that received BMT without Treg cells (N = 3). In contrast, 2 of 5 recipients of Treg cell BMT that were evaluable displayed chimerism in all lineages, including T cells, for up to 335 days post-BMT. Importantly, in the animal that survived long-term, greater than 90% of donor T cells were CD45RA CD31, suggesting they were new thymic emigrants. In this animal, the delayed (to 4 months) donor kidney graft was accepted more than 294 days without immunosuppression, whereas non-Treg cell BMT recipients rejected delayed donor kidneys within 3 to 4 weeks. Early CMV reactivation and treatment was associated with early failure of chimerism, regardless of Treg cell administration. Our studies provide proof-of-principle that, in the absence of early CMV reactivation (and BM-toxic antiviral therapy), cotransplantation of host Treg cell can promote prolonged and high levels of multilineage allogeneic chimerism and robust tolerance to the donor.